[Effect of a new lipid-reducing preparation (Etofibrat) on hyperlipoproteinemia type II. 2].
D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010919:Placebos
D008077:Lipoproteins, LDL; D010919:Placebos; D002994:Clofibrate
Wirkung eines neuen lipid-senkenden Medikamentes (Etofibrat) bei Hyperlipoproteinämien vom Typ II. 2